My Companies
Notification
Account
Log Out
Login
Gujarat Themis Biosyn initiated arbitration against Optimus Drugs for terminating a supply agreement, claiming Rs 75 crore break fees, Rs 15 crore damages, and interest on delayed payments, with no expected financial penalty.
Gujarat Themis Biosyn Completes JPY 21.5 Billion MicroBiopharm Japan Acquisition
Gujarat Themis Biosyn Allots Rs 585 Crore NCDs To Fund MBJ Acquisition
Gujarat Themis Biosyn Approves ₹585 Crore Unlisted NCD Programme
Gujarat Themis Biosyn Board Approves ₹335 Crore Preferential Share Issue
Gujarat Themis Biosyn Closes ₹750 Crore QIP At ₹354 Per Share